Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIENCY) (Unaudited) - 9 months ended Sep. 30, 2016 - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2015 $ 23,929 $ 4,720,417 $ (10,502,595) $ (5,758,249)
Balance (in shares) at Dec. 31, 2015 23,929,256      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Shares issued as debt discount in connection with extension of notes payable $ 500 199,500   200,000
Shares issued as debt discount in connection with extension of notes payable (in shares) 500,000      
Stock-based compensation : warrants   71,556   71,556
Net loss     (2,324,580) (2,324,580)
Balance at Sep. 30, 2016 $ 24,429 $ 4,991,473 $ (12,827,175) $ (7,811,273)
Balance (in shares) at Sep. 30, 2016 24,429,256